These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6129905)

  • 1. Cerebrospinal fluid zinc concentrations in ex-heroin addicts and patients with schizophrenia: some preliminary observations.
    Potkin SG; Shore D; Torrey EF; Weinberger DR; Gillin JC; Henkin RI; Agarwal RP; Wyatt RJ
    Biol Psychiatry; 1982 Nov; 17(11):1315-22. PubMed ID: 6129905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF copper concentrations in chronic schizophrenia.
    Shore D; Potkin SG; Weinberger DR; Torrey EF; Henkin RI; Agarwal RP; Gillin JC; Wyatt RJ
    Am J Psychiatry; 1983 Jun; 140(6):754-7. PubMed ID: 6133465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin, dopamine and schizophrenia.
    Garver DL; Beinfeld MC; Yao JK
    Psychopharmacol Bull; 1990; 26(3):377-80. PubMed ID: 2274639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
    Sedvall G
    Prog Biochem Pharmacol; 1980; 16():133-40. PubMed ID: 6160594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ERPs changes during neuroleptic treatment in schizophrenia--a vulnerability marker in schizophrenia].
    Asato N; Hirayasu Y; Hiramatsu K; Ohta H
    Seishin Shinkeigaku Zasshi; 1999; 101(3):254-76. PubMed ID: 10375977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inpatient withdrawal treatment of heroin dependence with neuroleptics--an approach to addicts].
    Presslich O; Schanda H; Hermann P
    Psychiatr Prax; 1983 Mar; 10(2):60-3. PubMed ID: 6134297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroleptic therapy of comorbid narcotic dependent patients in ambulatory methadone maintenance].
    Unglaub W; Kandel M; Zenner D; Wodarz N; Klein H
    Psychiatr Prax; 2003 May; 30 Suppl 2():S121-4. PubMed ID: 14509056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low prolactin levels in cerebrospinal fluid: an after effect of lobotomy in chronic schizophrenia.
    Hyyppä MT; Liira J; Kampman R; Rimòn R
    Acta Psychiatr Belg; 1980; 80(4):452-7. PubMed ID: 7282416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication.
    Glovinsky D; Kalogeras KT; Kirch DG; Suddath R; Wyatt RJ
    Schizophr Res; 1994 Feb; 11(3):273-6. PubMed ID: 7910756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procedural learning in schizophrenia: further consideration on the deleterious effect of neuroleptics.
    Bédard MA; Schérer H; Stip E; Cohen H; Rodriguez JP; Richer F
    Brain Cogn; 2000; 43(1-3):31-9. PubMed ID: 10857658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethnic comparisons of antipsychotic use in schizophrenia.
    Wheeler A; Humberstone V; Robinson E
    Aust N Z J Psychiatry; 2008 Oct; 42(10):863-73. PubMed ID: 18777230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta-endorphin concentration in the cerebrospinal fluid of schizophrenics].
    Ignatov SA; Burbaeva GSh; Tsutsul'kovskaia MIa; Abramova LI; Trubnikov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(9):1331-7. PubMed ID: 6108032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine production in drug-free and neuroleptic-treated schizophrenic patients.
    Bessler H; Levental Z; Karp L; Modai I; Djaldetti M; Weizman A
    Biol Psychiatry; 1995 Sep; 38(5):297-302. PubMed ID: 7495923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.
    Szulc A; Galińska B; Tarasów E; Kubas B; Dzienis W; Konarzewska B; Poplawska R; Tomczak AA; Czernikiewicz A; Walecki J
    Med Sci Monit; 2007 May; 13 Suppl 1():17-22. PubMed ID: 17507880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manganese, copper, and zinc in cerebrospinal fluid from patients with multiple sclerosis.
    Melø TM; Larsen C; White LR; Aasly J; Sjøbakk TE; Flaten TP; Sonnewald U; Syversen T
    Biol Trace Elem Res; 2003; 93(1-3):1-8. PubMed ID: 12835484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do neuroleptics cause depression?
    Roy A
    Biol Psychiatry; 1984 May; 19(5):777-81. PubMed ID: 6145454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic drug utilisation for acute schizophrenia.
    Razali MS; Hasanah CI
    Singapore Med J; 1996 Dec; 37(6):611-3. PubMed ID: 9104062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of retinoid transporters expression in body fluids of schizophrenia patients.
    Wan C; Yang Y; Li H; La Y; Zhu H; Jiang L; Chen Y; Feng G; He L
    J Proteome Res; 2006 Nov; 5(11):3213-6. PubMed ID: 17081074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome.
    Nemeroff CB; Bissette G; Widerlov E; Beckmann H; Gerner R; Manberg PJ; Lindstrom L; Prange AJ; Gattaz WF
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):16-20. PubMed ID: 2577718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.